Shares of Catalyst Pharmaceuticals rose 3.07% to $3.53 at 13:48 EST on Monday, after five successive sessions in a row of losses. NASDAQ Composite is jumping 0.87% to $12,916.24, following last session's upward trend, This seems, up until now, a somewhat positive trend trading session today.
Catalyst Pharmaceuticals's last close was $3.42, 49.79% under its 52-week high of $5.28.
Catalyst Pharmaceuticals's Sales
Catalyst Pharmaceuticals's sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company's growth estimates for the current quarter is 25% and a drop 10% for the next.
Catalyst Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals's Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals's stock is valued at $3.53 at 13:48 EST, way under its 52-week high of $5.28 and way above its 52-week low of $2.55.